Cosentyx (300 MG Dose) and Insulin glargine
Determining the interaction of Cosentyx (300 MG Dose) and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Cosentyx
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cosentyx (300 MG Dose)-Insulin Glargine (U-100) Cartridge Systems and Pens
- Cosentyx (300 MG Dose)-Insulin Glargine (U-100) Vials
- Cosentyx (300 MG Dose)-Insulin Glargine (U-300) Pens
- Cosentyx (300 MG Dose)-Insulin glargine and lixisenatide
- Cosentyx (300 MG Dose)-Insulin glargine and lixisenatide Subcutaneous
- Cosentyx (300 MG Dose)-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Cosentyx Sensoready (300 MG)
- Insulin glargine-Cosentyx Sensoready Pen
- Insulin glargine-Cosmegen
- Insulin glargine-Cosopt
- Insulin glargine-Cosopt Ocumeter
- Insulin glargine-Cosopt Ocumeter Plus